Can we detect misfolded α-Synuclein in blood 10 years prior to a diagnosis of Parkinson's disease? Kluge, Berg and colleagues say YES in a just published small study in Movement Disorders Journal.
Key Points:
- The authors cite the increasing importance of our ability to identify potential…

🥳we are live: realad.se

Today, we launched REAL AD! In this large naturalistic study, we aim to explore the feasibility and diagnostic abilities of remote cognitive testing and blood biomarkers to detect early Alzheimer’s disease in the general population.

Nicolas Villain Simon Mead Timothy Daly, PhD Madhav Thambisetty Eric Widera, MD Andrew Lees Robert Howard Jason Cohen radical optimism Lon S. Schneider, MD Seb Walsh Michael Schöll Vincent Planche Stefano L. Sensi Alberto J Espay Kasper Planeta Kepp Gill Livingston Ryan Townley Jesse F Ballenger (mastodon.world/@jfballenger) Jason Karlawish James Rupert Fletcher Adam M. Brickman Dr. Jennifer Manly Sarah Ackley, PhD FORTUNE TIME Erin Prater TIME Financial Times Hannah Kuchler CTAD NIH Alzheimer's Association Howard Gleckman American Geriatrics Society Kathy Liu Richard Merrick Nancy Lundebjerg (she/her/hers) Nathaniel Chin U.S. FDA NICE Raymond Koopmans Maastricht University Kariem Ezzat Dr Ben Underwood NHS England The Observer IQWiG - Account stillgelegt / Account inactive The Labour Party Risk of conversion to mild cognitive impairment or dementia among subjects with amyloid and tau pathology: a systematic review and meta-analysis alzres.biomedcentral.com/articles/10.11… via Gábor Csukly et al

Press release: BioArctic and Eisai sign research evaluation agreement regarding a potential new treatment combining BioArctic’s proprietary BrainTransporter™ technology with an undisclosed Alzheimer drug candidat. bioarctic.se/en/bioarctic-a…

Serum GFAP levels correlate with astrocyte reactivity, post-mortem brain atrophy and neurofibrillary tangles academic.oup.com/brain/article/…

Out now in The Lancet Neurology A comparison of tau PET pathology in Down Syndrome (DS) and Autosomal Dominant Alzheimer Disease (ADAD).
thelancet.com/journals/laneu…

Rejoignez-nous le 2 mai à la Hôpital Pitié Salpêtrière - AP-HP pour une soirée débat sur les troubles neuro fonctionnels dans ce lieu mythique et symbolique qui reflète bien l’évolution de nos connaissances depuis Charcot!
L’occasion d’écouter le nouvel épisode du serment d’Augusta!

New paper alert from the ⁦Memento Cohort⁩ in the ⁦Neurology Journal⁩ ! Associations Between Blood-Based Biomarkers and Cognitive and Functional Trajectories Among Participants of the MEMENTO Cohort | Neurology neurology.org/doi/10.1212/WN…

Thank you all for submitting your poster and Datablitz applications. Our Scientific Committee will be in touch with you shortly to announce which candidates have been selected.